TI
RLAY icon

Trexquant Investment’s Relay Therapeutics RLAY Stock Holding History

Trexquant Investment’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.84M Buy
152,017
+57,769
+61% +$839K 0.02% 1028
2026
Q1 		$938K Sell
94,248
-377,797
-80% -$3.38M 0.01% 1249
2025
Q4 		$3.99M Buy
+472,045
New +$3.37M 0.04% 693
2025
Q2 		– Sell
-324,469
Closed -$850K – 1820
2025
Q1 		$850K Sell
324,469
-653,668
-67% -$2.56M 0.01% 1136
2024
Q4 		$4.03M Buy
978,137
+566,275
+137% +$3.08M 0.05% 602
2024
Q3 		$2.92M Buy
411,862
+227,241
+123% +$1.7M 0.04% 673
2024
Q2 		$1.2M Buy
+184,621
New +$1.26M 0.02% 937
2024
Q1 		– Sell
-128,890
Closed -$1.42M – 1729
2023
Q4 		$1.42M Sell
128,890
-69,781
-35% -$589K 0.03% 690
2023
Q3 		$1.67M Buy
198,671
+179,317
+927% +$1.93M 0.04% 550
2023
Q2 		$243K Buy
+19,354
New +$241K 0.01% 1259
2023
Q1 		– Sell
-21,684
Closed -$324K – 1720
2022
Q4 		$324K Buy
+21,684
New +$415K 0.01% 1075
2022
Q3 		– Sell
-183,287
Closed -$3.07M – 1771
2022
Q2 		$3.07M Buy
+183,287
New +$3.93M 0.14% 167
2021
Q2 		– Sell
-8,482
Closed -$293K – 1442
2021
Q1 		$293K Buy
+8,482
New +$368K 0.03% 767

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Trexquant Investment's RLAY Position: Q2 2026 in Review

Trexquant Investment increased its Relay Therapeutics (RLAY) stake by 61% in Q2 2026, buying an estimated $839K and bringing the position to 152,017 shares worth $2.84M. The position accounts for 0.02% of the portfolio, ranked #1028.

Trexquant Investment first reported a position in RLAY in Q1 2021 and has held it in 13 quarters since. The position peaked at $4.03M in Q4 2024. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Trexquant Investment held 152,017 shares of Relay Therapeutics worth $2.84M as of Q2 2026.
  • Trexquant Investment bought 57,769 Relay Therapeutics shares in Q2 2026, an estimated $839K.
  • Relay Therapeutics made up 0.02% of Trexquant Investment's portfolio in Q2 2026, its #1028 holding.
  • Trexquant Investment first reported a position in Relay Therapeutics in Q1 2021 and has held it in 13 quarters since.
  • Trexquant Investment's Relay Therapeutics position peaked at $4.03M in Q4 2024.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.